financetom
Business
financetom
/
Business
/
Pegasystems Insider Bought Shares Worth $504,218, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pegasystems Insider Bought Shares Worth $504,218, According to a Recent SEC Filing
Jun 13, 2024 2:39 PM

05:14 PM EDT, 06/13/2024 (MT Newswires) -- Sharon T Rowlands, Director, on June 11, 2024, executed a purchase for 8,600 shares in Pegasystems ( PEGA ) for $504,218. Following the Form 4 filing with the SEC, Rowlands has control over a total of 30,871 shares of the company, with 30,871 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1013857/000101385724000135/xslF345X03/wk-form4_1718312781.xml

Price: 57.75, Change: +0.50, Percent Change: +0.87

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Flower Foods Fiscal Q2 Adjusted Earnings Fall, Sales Rise; Fiscal 2025 Outlook Lowered
Flower Foods Fiscal Q2 Adjusted Earnings Fall, Sales Rise; Fiscal 2025 Outlook Lowered
Aug 15, 2025
07:14 AM EDT, 08/15/2025 (MT Newswires) -- Flower Foods (FLO) reported fiscal Q2 adjusted earnings Friday of $0.30 per diluted share, down from $0.36 a year earlier. Analysts surveyed by FactSet expected $0.30. Net sales for the quarter ended July 12 were $1.24 billion, up from $1.22 billion a year earlier. Analysts polled by FactSet expected $1.27 billion. For fiscal...
US FDA approves Precigen's immunotherapy for rare respiratory disease
US FDA approves Precigen's immunotherapy for rare respiratory disease
Aug 15, 2025
By Sneha S K and Kamal Choudhury Aug 15 (Reuters) - The U.S. Food and Drug Administration has approved Precigen's ( PGEN ) immunotherapy to treat adults with a rare respiratory disease, making it the first treatment for the condition to receive the health regulator's nod. The therapy, Papzimeos, was approved to treat recurrent respiratory papillomatosis (RRP) - a condition...
BitFufu Q2 Earnings Rise, Revenue Falls; Shares up Pre-Bell
BitFufu Q2 Earnings Rise, Revenue Falls; Shares up Pre-Bell
Aug 15, 2025
07:14 AM EDT, 08/15/2025 (MT Newswires) -- BitFuFu ( FUFU ) reported Q2 earnings Friday of $0.28 per diluted share, up from $0.01 a year earlier. Analysts polled by FactSet expected $0.06. Revenue for the quarter ended June 30 was $115.4 million, compared with $129.4 million a year earlier. Analysts surveyed by FactSet expected $123.7 million. The company's shares were...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved